December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreNovember 01, 2025
According to market projections, the autoimmune hepatitis diagnosis and treatment sector is expected to grow from USD 14.49 billion in 2024 to USD 20.05 billion by 2034, reflecting a CAGR of 3.3%. The autoimmune hepatitis diagnosis and treatment market focuses on tests and therapies for managing autoimmune hepatitis, a condition where the immune sy...
November 01, 2025
According to market projections, the vein finder sector is expected to grow from USD 53.43 million in 2024 to USD 123.04 million by 2034, reflecting a CAGR of 8.7%. In 2023, near-infrared technology led the vein finder market with a 57% share, while tabletop models dominated at 55%. Hospitals and clinics were the top users, holding 62% of the marke...
November 01, 2025
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2024 to USD 632.09 billion by 2034, achieving a CAGR of 10.1%. In 2024, North America led the market, while Asia-Pacific is the fastest-growing region. Drug delivery dominated by application, but therapeutics is set for rapid growth. Clinical oncology ...
November 01, 2025
According to market projections, the newborn screening sector is expected to grow from USD 3.44 billion in 2024 to USD 6.46 billion by 2034, reflecting a CAGR of 6.5%. The market is growing due to rising demand for preventive care, advanced diagnostic technologies, and increased awareness of testing. Recent highlights include the GUARDIAN study usi...
November 01, 2025
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital pharmacies dominated distribution at 50%. North America was the top region. Key players include ViiV...
November 01, 2025
According to forecasts, the global alopecia areata market will grow from USD 3.32 billion in 2024 to USD 6.92 billion by 2034, with an expected CAGR of 7.6%. AI is transforming the Alopecia Areata market by improving diagnosis, treatment, and research. It enables early detection through advanced analysis, allowing for timely intervention. AI also a...
November 01, 2025
According to market projections, the global multiple sclerosis diagnosis and treatment market, valued at USD 22.89 billion in 2024, is anticipated to reach USD 31.98 billion by 2034, growing at a CAGR of 3.4% over the next decade. Advancements in technology aid early diagnosis and better prevention for multiple sclerosis (MS), reducing its economic...
November 01, 2025
Market insights predict the global cervical spondylosis diagnosis and treatment industry will increase from USD 6.63 billion in 2024 to USD 12.67 billion by 2034, achieving a CAGR of 6.7%. In 2023, medications dominated the Cervical Spondylosis Diagnosis & Treatment Market with a 38% share, while hospital pharmacies led with 40%. The Asia Pacif...
November 01, 2025
According to market projections, the tendonitis treatment sector is expected to grow from USD 221.97 billion in 2024 to USD 316.15 billion by 2034, reflecting a CAGR of 3.6%. In 2023, therapies were the top choice for treating tendonitis, holding a 65% market share, while medications accounted for 25%. North America led the market with a 42% share,...
November 01, 2025
Based on market forecasts, the osteoarthritis sector will expand from USD 9.32 billion in 2024 to USD 20.88 billion by 2034, experiencing a CAGR of 8.4%. In 2023, knee osteoarthritis led the market with a 49% share due to its high prevalence. Imaging tests dominated diagnostics, while North America held a 38% market share. Key players include Zimme...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com